Showing 1661-1670 of 2165 results for "".
84. Case Reflection: Contact Lens Abuser
https://modernod.com/podcasts/four-eyes/84-case-reflection-contact-lens-abuser/37034/In this episode of our New Grad Case Reflection series, we dive into the challenges of managing a patient who consistently abused their contact lens wear. Patient education on contact lens hygiene is vital, but what happens when they ignore your advice? Join Dr. Bilkhu as she reflects on her experieBreaking News From the AAO Meeting in Chicago
https://modernod.com/podcasts/eyewire-news-the-podcast/breaking-news-from-the-aao-meeting-in-chicago/37055/Eyewire News: The Podcast reports on new products and breaking news live from the American Academy of Ophthalmology meeting in Chicago.B+L Receives FDA Approval for enVista Envy IOL
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-receives-fda-approval-for-envista-envy-iol/37054/Bausch + Lomb receives FDA approval for a new IOL on its enVista platform; Nanoscope advances it gene therapy for retinitis pigmentosa; and Orasis completes a major funding round to support the launch of its presbyopia eye drop.Aldeyra Resubmits NDA for DED Drug Reproxalap
https://modernod.com/podcasts/eyewire-news-the-podcast/aldeyra-resubmits-nda-for-ded-drug-reproxalap/37053/Aldeyra resubmits its NDA for dry eye drug reproxalap; Clearside announces new phase 2b topline data for its investigational extended-release wet AMD drug; and Bausch + Lomb launches a new digital e-commerce marketplace.The Optometrist’s Guide to Fuchs Endothelial Corneal Dystrophy
https://modernod.com/topics/corneaanterior-segment/the-optometrists-guide-to-fuchs-endothelial-corneal-dystrophy/38873/Know what to look for, how to look for it, and how to treat it.Two Partnerships Formed to Advance Glaucoma Treatments
https://modernod.com/podcasts/eyewire-news-the-podcast/two-partnerships-formed-to-advance-glaucoma-treatments/37051/Two collaborations are made to develop and market new glaucoma treatments; Apellis receives feedback from a committee of thee EMA for its geographic atrophy treatment pegcetacoplan; and Topcon receives FDA clearance for OCTA on the company’s Maestro2 fundus camera system.Weekly Headlines: Zeiss Lenticule Extraction for Hyperopia
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-09112024/37049/Zeiss Lenticule Extraction for Hyperopia • Alcon Ngenuity 1.5 • Oculus Pentacam Cornea OCT • Lensar ALLY Adaptive Cataract Treatment System • BVI Serenity IOLs • Topcon TRK-OmniaWeekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-09042024/37048/First Therapy for Acanthamoeba Keratitis Approved in Europe • Oculus Adds Dual Testing Functionality to Easyfield VR • FDA Clears IND Application for Stem Cell Therapy for Primary Photoreceptor DiseasesHow to Make Better Purchasing Decisions for Your Practice
https://modernod.com/topics/business/how-to-make-better-purchasing-decisions-for-your-practice/38845/Keep these considerations in mind when deciding what to invest in and what to avoid.Five Tips for Creating a More Effective Work Environment
https://modernod.com/topics/business/five-tips-for-creating-a-more-effective-work-environment/38844/Consider incorporating these pearls to improve your delegation and organization needs.